Showing results for cancer care
Mesothelioma prognosis is a topic that patients and families often approach with a mix of urgency and caution. While no one can predict an exact outcome for a specific person, clinicians can outline the likely course of the disease based on several well est...
TNBC treatment in the United States has evolved rapidly over the past decade, driven by advances in immunotherapy, targeted therapies, and antibody drug conjugates. Triple negative breast cancer, defined by the absence of estrogen and progesterone receptors...
Trodelvy, also known by its generic name sacituzumab govitecan, has established a distinctive role in the treatment landscape of breast cancer. It is most prominently used in metastatic breast cancer settings where previous lines of therapy have failed, off...
